Mattia Colucci
Overview
Explore the profile of Mattia Colucci including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
23
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tamiro F, Padovano C, De Santis E, Di Iasio S, Sansico F, Canistro V, et al.
Blood
. 2025 Feb;
PMID: 40009499
T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive malignancy characterized by an expansion of T-cell progenitors and DNA mutations that lead to an overactive NOTCH1 signaling in over 50% of...
2.
Padovano C, Bianco S, Sansico F, De Santis E, Tamiro F, Colucci M, et al.
Sci Rep
. 2023 Dec;
13(1):21199.
PMID: 38040752
Notch signaling is an evolutionary conserved pathway with a key role in tissue homeostasis, differentiation and proliferation. It was reported that Notch1 receptor negatively regulates mouse osteoclast development and formation...
3.
Colucci M, Trivieri N, Mencarelli G, De Santis E, Sansico F, Tamiro F, et al.
Biomark Res
. 2023 Oct;
11(1):92.
PMID: 37858274
T-cell lymphoblastic acute leukemia (T-ALL) is an aggressive blood cancer, characterized by restricted cellular subsets with enriched leukemia initiating cells (LICs). Recently, Ephrin receptors (Eph) were described to be highly...
4.
Murgo E, De Santis E, Sansico F, Melocchi V, Colangelo T, Padovano C, et al.
J Exp Clin Cancer Res
. 2023 Aug;
42(1):218.
PMID: 37620852
Background: T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive hematological malignancy, characterized by restricted cellular subsets with asymmetrically enriched leukemia initiating cell (LIC) activity. Nonetheless, it is still unclear which...
5.
Panelli P, De Santis E, Colucci M, Tamiro F, Sansico F, Miroballo M, et al.
Blood
. 2022 Oct;
141(13):1597-1609.
PMID: 36315912
T-cell acute lymphoblastic leukemia (T-ALL) is a T-cell malignancy characterized by cell subsets and enriched with leukemia-initiating cells (LICs). β-Catenin modulates LIC activity in T-ALL. However, its role in maintaining...
6.
Colucci M, Frezza D, Gambassi G, De Vito F, Iaquinta A, Massaro M, et al.
Gene
. 2022 Jun;
838:146698.
PMID: 35772651
Purpose: The pandemic diffusion of Coronavirus Disease 2019 (COVID-19) has highlighted significant gender-related differences in disease severity. Despite several hypotheses being proposed, how the genetic background of COVID-19 patients might...
7.
Sansico F, Miroballo M, Bianco D, Tamiro F, Colucci M, De Santis E, et al.
Biomedicines
. 2021 Dec;
9(12).
PMID: 34944610
COVID-19 is a viral infection, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and characterized by a complex inflammatory process and clinical immunophenotypes. Nowadays, several alterations of immune...
8.
Colucci M, De Santis E, Totti B, Miroballo M, Tamiro F, Rossi G, et al.
Vaccines (Basel)
. 2021 Oct;
9(10).
PMID: 34696315
The escalation of Coronavirus disease 2019 (COVID-19) has required the development of safe and effective vaccines against the severe acute respiratory syndrome coronavirus 2-associated (SARS-CoV-2), which is the causative agent...